NK92 cells stably transfected with CD16 are efficient against multiple myeloma cells ex vivo and in vivo, especially if combined with daratumumab

Giraldos, David Galano-Frutos, Evelyn Cambronero-Arregui, Laura Beltrán Visiedo, Manuel Romanos, Eduardo Reina-Ortiz, Chantal Azaceta, Gemma Martínez-Lázaro, Beatriz Menéndez-Jándula, Bárbara García-Romero, Alejandro Jiménez-Albericio, Francisco Javier Marzo, Isabel Naval, Javier Anel, Alberto NK92 cells stably transfected with CD16 are efficient against multiple myeloma cells ex vivo and in vivo, especially if combined with daratumumab

Oncoimmunology

10.1080/2162402X.2025.2559782 2025

2025